Shoulder Innovations, Inc. (SI) Free Cash Flow Yield: N/A
The free cash flow yield for Shoulder Innovations, Inc. (SI) is N/A as of Sunday, June 21, 2026.
SI Free Cash Flow Yield Chart
SI Average Free Cash Flow Yield Chart
SI Free Cash Flow Yield Metrics
FREE CASH FLOW YIELD
N/A
FREE CASH FLOW YIELD AVG TTM
-9.13%
FREE CASH FLOW YIELD AVG 3Y
N/A
FREE CASH FLOW YIELD AVG 5Y
N/A
FREE CASH FLOW YIELD AVG 10Y
N/A
FREE CASH FLOW YIELD AVG 15Y
N/A
FREE CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SI Competitors' Free Cash Flow Yield
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $384.69M | N/A | -9.13% | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | -496.25% | -255.12% | -171.49% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | 5.04% | 4.99% | 5.60% | 5.61% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 5.31% | 2.37% | 2.37% | 2.37% |
| Oscar Health, Inc. (OSCR)vs › | $7.36B | 29.85% | 24.65% | 20.36% | 18.94% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 4.69% | 4.52% | 3.14% | 2.79% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 0.94% | 1.42% | 1.61% | 1.61% |
| Tempus AI, Inc. (TEM)vs › | $8.87B | N/A | -3.09% | -3.23% | -3.23% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 4.32% | 6.24% | 5.04% | 4.15% |
| Baxter International Inc. (BAX)vs › | $10.27B | 6.97% | 3.27% | 3.94% | 3.75% |
Yield Comparison
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
- Shows free cash flow after capital expenditures relative to market cap
- Can be compared with earnings yield and dividend yield
- Can be compared with the company's historical range
- Can be compared with peers that report positive free cash flow
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
Shoulder Innovations, Inc. Free Cash Flow Yield Formula & Definition
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shoulder Innovations, Inc. Free Cash Flow Yield FAQ
- What is the free cash flow yield for Shoulder Innovations, Inc. (SI)?
- The free cash flow yield for SI stock is N/A.
- What is the TTM average free cash flow yield for Shoulder Innovations, Inc. (SI)?
- The TTM average free cash flow yield for SI stock is -9.13%.
Shoulder Innovations, Inc. Free Cash Flow Yield History
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2025-12-31 | -12.21% |
| 2024-12-31 | -6.06% |
| 2023-12-31 | -5.30% |
About Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a medical technology firm that engineers and produces sophisticated devices. The company is particularly recognized for designing an innovative shoulder replacement system. Co-founded in 2009 by Stephen B. Gunther and Michael DeVries, its main corporate office is situated in Grand Rapids, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Alan J. Lane